Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Factor |
Reference |
AUC |
100000.0 |
ng.h/ml |
100.0 |
mcg.h/ml |
PO, oral; |
|
DRUGBANK |
AUC |
124000.0 |
ng.h/ml |
124.0 |
mcg.h/ml |
Active metabolite; |
|
DRUGBANK |
Bioavailability |
100.0 |
% |
~100 |
% |
PO, oral; |
|
DRUGBANK |
C Max |
6000.0 |
ng/ml |
6.0 |
mcg/ml |
PO, oral; |
|
DRUGBANK |
C Max |
5900.0 |
ng/ml |
5.9 |
mcg/ml |
Active metabolite; |
|
DRUGBANK |
T Max |
2.0 |
h |
2(1-5) |
h |
PO, oral; |
|
DRUGBANK |
Tss |
672.0 |
h |
4 |
week |
PO, oral; |
|
DRUGBANK |
Clearance |
1.3 |
L/h |
1.3 |
L/h |
apparent clearance; Single dose; |
extended release formulation ↑ ; |
DRUGBANK |
Clearance |
2.0 |
L/h |
2.0 |
L/h |
apparent clearance; Multiple dose; at steady state; |
|
DRUGBANK |
Volume of Distribution |
276.0 |
L |
~276 |
L |
Apparent volume of distribution; at steady state; |
|
DRUGBANK |
Half-life |
72.0 |
h |
~3 |
day |
effective half-life; NM-CRPC; patients; at steady state; |
|
DRUGBANK |
Eliminate Route |
65.0 |
% |
65 |
% |
Urinary excretion; Oral single dose; |
|
DRUGBANK |
Eliminate Route |
24.0 |
% |
24 |
% |
Faeces excretion; Oral single dose; |
|
DRUGBANK |
Eliminate Route |
0.78 |
% |
0.78 |
% |
Urinary excretion; Oral single dose; Unchanged drug; |
|
DRUGBANK |
Eliminate Route |
0.36 |
% |
0.36 |
% |
Faeces excretion; Oral single dose; Unchanged drug; |
|
DRUGBANK |
Protein Binding |
96.0 |
% |
96 |
% |
|
|
DRUGBANK |